First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
ICOS激动剂feladilimab治疗晚期实体瘤患者的首次人体I期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011475
Maio, Michele; Moreno, Victor; Martin-Liberal, Juan; Opdam, Frans; Hansen, Aaron; Bauer, Todd M; Le Tourneau, Christophe; Italiano, Antoine; Rischin, Danny; Ellis, Catherine; Turner, David; Yadavilli, Sapna; Zhou, Helen; Hirschfeld, Steven; Ballas, Marc; Diaz-Padilla, Ivan; Angevin, Eric
